Roy Doumani
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Roy Doumani
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
University of California, Los Angeles
280
| College/University | Other Consumer Services | 280 |
| Subsidiary | Biotechnology | 45 | |
Xiamen International Bank Co., Ltd.
 Xiamen International Bank Co., Ltd. Major BanksFinance Xiamen International Bank Co., Ltd. engages in the provision of commercial banking services. Its business scopes include personal and corporate deposits, loans, bonds, settlements, interbank borrowing, foreign exchanges, insurance, and credit services. The company was founded on August 31, 1985 and is headquartered in Shenzhen, China.
19
| Subsidiary | Major Banks | 19 |
David Geffen School of Medicine
7
| College/University | Other Consumer Services | 7 |
Zhejiang California International Nanosystems Institute
1
| Private Company | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Roy Doumani tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Founder Founder Founder Director/Board Member General Counsel Chief Tech/Sci/R&D Officer Founder General Counsel | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Private Equity Investor Sales & Marketing Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Founder Founder Private Equity Investor Consultant / Advisor Consultant / Advisor | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Executive Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| UROGEN PHARMA LTD. | Biotechnology | Chairman Director/Board Member Consultant / Advisor Director/Board Member Director/Board Member | |
| Xiamen University | College/University | Masters Business Admin Director of Finance/CFO Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
| ARNO THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Founder Chairman Director/Board Member Treasurer | |
| KRONOS BIO, INC. | Pharmaceuticals: Major | Founder Founder Founder Consultant / Advisor | |
IconOVir Bio, Inc.
 IconOVir Bio, Inc. BiotechnologyHealth Technology IconOVir Bio, Inc. is an American biotechnology company that operates in the field of life sciences. The company was founded in 2018 by Arie S. Belldegrun, Ben Stone. The CEO is Mark A. McCamish. | Biotechnology | Founder Founder Director/Board Member Chairman | |
| GILEAD SCIENCES, INC. | Biotechnology | Director of Finance/CFO General Counsel Compliance Officer Corporate Officer/Principal | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
| CAPRICOR THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Secretary Director/Board Member Director/Board Member Treasurer | |
Two River Group Holdings LLC
 Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | Investment Managers | Founder Founder Chairman Private Equity Investor | |
| MIN XIN HOLDINGS LIMITED | Insurance Brokers/Services | Director/Board Member Chairman Chairman Chairman | |
Riverbank Capital Securities, Inc.
 Riverbank Capital Securities, Inc. Investment Banks/BrokersFinance Part of Two River Group Holdings LLC, Riverbank Capital Securities, Inc. deals securities. The company is based in New York, NY. | Investment Banks/Brokers | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Neogene Therapeutics, Inc.
 Neogene Therapeutics, Inc. BiotechnologyHealth Technology Neogene Therapeutics, Inc. engages in the provision T cell therapies to treat cancer. The company was founded by Ton N. M. Schumacher and Carsten Linnemann and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
Kite Pharma UK Ltd.
 Kite Pharma UK Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Kite Pharma UK Ltd. is a subsidiary of Gilead Sciences, Inc. that engages in research and develops clinical trials. The company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Two River Consulting LLC
 Two River Consulting LLC Miscellaneous Commercial ServicesCommercial Services Two River Consulting LLC provides management consulting services. The private company is based in Franklin Lakes, NJ. The company was founded by David M. Tanen. | Miscellaneous Commercial Services | Founder Director of Finance/CFO Corporate Officer/Principal | |
76bio, Inc.
 76bio, Inc. Pharmaceuticals: MajorHealth Technology 76Bio, Inc. is a private company that aims to develop transformational therapies for patients with life-threatening diseases. The company is based in New York, NY. The company focuses on pioneering the next generation of degradation by design. 76Bio was founded by Joshua A. Kazam, David M. Tanen, Marius Pop, Christopher Wilfong, Ben Stone, Angela Koehler, Arie S. Belldegrun, and K. Dane Wittrup. Christopher Wilfong has been the CEO since incorporation. | Pharmaceuticals: Major | Founder Founder Founder | |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Miscellaneous Commercial Services | Founder Director/Board Member Chief Tech/Sci/R&D Officer | |
| XIAMEN C&D INC. | Air Freight/Couriers | Director/Board Member Director/Board Member Director/Board Member | |
| CELGENE | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Vida Ventures LLC
 Vida Ventures LLC Investment ManagersFinance Vida Ventures LLC invests in companies located in the United States. The fund targets companies operating in the fields of life science innovation. It provides financing for seed, early and later stage capital requirements. | Investment Managers | Founder Corporate Officer/Principal Director/Board Member | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Sales & Marketing | |
Fujian Investment & Development Group Co., Ltd.
 Fujian Investment & Development Group Co., Ltd. Financial ConglomeratesFinance Fujian Investment & Development Group Co., Ltd. provides investment services. The company is based in Fuzhou, China. The Chinese company is ultimately controlled by the Province of Fujian. Hui Xie has been the CEO of the company since 2009. | Financial Conglomerates | Chairman Chief Executive Officer Corporate Officer/Principal | |
| George Washington University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
D3C1 Allston Co-Investment LP
 D3C1 Allston Co-Investment LP Financial ConglomeratesFinance Part of Breakthrough Properties LLC, D3C1 Allston Co-Investment LP functions as an investment fund. The company is based in Los Angeles, CA. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Appia Bio, Inc.
 Appia Bio, Inc. BiotechnologyHealth Technology Appia Bio, Inc. is an early stage biotechnology company based in an undisclosed location. Appia Bio is focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. The American company utilizes the biology of lymphocyte development with chimeric antigen receptor (CAR) and T cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-NKT) or gamma delta T cells from hematopoietic stem cells (HSCs) with its ACUA (Appia Cells Utilized for Allogeneic) technology platform. The ACUA platform was developed from groundbreaking research in the laboratory of Lili Yang, Ph.D., at the University of California, and collaboration with Appia Bio's other scientific founders, David Baltimore, Ph.D. at Caltech and Pin Wang, Ph.D. at the University of Southern California. The company was founded in 2020 by Jeffrey S. Wiezorek, David Baltimore, Jeenjoo Kang, Lili Yang, Edmund Kim, and Pin Wang. Jeenjoo Kang has been the CEO since 2020. | Biotechnology | Director/Board Member Founder | |
Paramount BioCapital, Inc.
 Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States. | Investment Managers | Director/Board Member Corporate Officer/Principal | |
| The White House | General Government | Corporate Officer/Principal Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Corporate Officer/Principal Masters Business Admin | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree | |
| INSTIL BIO, INC. | Biotechnology | Chief Operating Officer Director/Board Member | |
| CELULARITY INC. | Miscellaneous Commercial Services | Director/Board Member Chief Operating Officer | |
| Breakthrough Services LLC | Director/Board Member Chairman | ||
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Sales & Marketing Chief Executive Officer | |
ByHeart, Inc.
 ByHeart, Inc. Miscellaneous Commercial ServicesCommercial Services ByHeart, Inc. engages in the provision of healthcare business. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Breakthrough Properties LLC
 Breakthrough Properties LLC Investment ManagersFinance Breakthrough Properties LLC engages in the provision of real estate development services. It offers best-in-class physical infrastructure, user-driven perspective, and mentorship. The company was founded by Dan Belldegrun and is headquartered in Los Angeles, CA. | Investment Managers | Director/Board Member Chairman | |
Kirax Corp.
 Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | Pharmaceuticals: Major | Founder Director/Board Member | |
| GAMIDA CELL LTD. | Pharmaceuticals: Major | Chairman Chief Operating Officer | |
Danube Pharmaceuticals, Inc.
 Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 45 |
| Cina | 4 |
| Hong Kong | 2 |
| Regno Unito | 2 |
| Svizzera | 2 |
Settori
| Health Technology | 23 |
| Finance | 12 |
| Consumer Services | 9 |
| Commercial Services | 7 |
| Transportation | 2 |
Posizioni
| Director/Board Member | 604 |
| Corporate Officer/Principal | 219 |
| Independent Dir/Board Member | 145 |
| Undergraduate Degree | 77 |
| Chairman | 77 |
Contatti più connessi
| Insiders | |
|---|---|
| David Fischel | 103 |
| David Bonderman | 89 |
| Franz Humer | 45 |
| Joshua Kazam | 43 |
| Arie Belldegrun | 42 |
| Ran Nussbaum | 38 |
| Ian Clark | 35 |
| Robin Washington | 34 |
| Helen Kim | 34 |
| Kavita Patel | 30 |
| Han Wen Chen | 28 |
| David Tanen | 25 |
| William G. Ouchi | 24 |
| Shawn Tomasello | 22 |
| Jonathan Peacock | 21 |
- Borsa valori
- Insiders
- Roy Doumani
- Connessioni Società
